EUROPE INTRAGASTRIC BALLOON MARKET 2019-2028

EUROPE INTRAGASTRIC BALLOON MARKET 2019-2028

MARKET OUTLOOK

As per a report by Triton Market Research on the intragastric balloon market in Europe, the market would surge at a CAGR of 12.07% during the projected years 2019-2028.

Germany, Spain, France, Italy, the United Kingdom, Russia and Rest of Europe comprise the intragastric balloon market in Europe.

Among the European countries, Germany has one of the highest population with obesity. Approximately 60% of the overall population in the country is either obese or grossly overweight. More than one million of these are children. The growing consumption of fatty foods and lack of physical activity is attributable to the high obesity rate in Germany. The rising obesity is causing high blood pressure issues among children and youth. Hence, the Federal Ministry of Health (BMG) and the Federal Ministry of Food, Agriculture and Consumer Protection (BMEL) have been promoting a healthy lifestyle, with a strong focus on the obesity problem. These factors are likely to drive the intragastric balloon market in the country.

In France, the alarming rise in obesity cases has been cited as a significant health issue in the past few years. It is reported that every tenth person in the country is obese. It is also estimated that the overweight rates will grow further by 10% in the next decade. Therefore, the increasing obesity rate will boost the intragastric balloon market in France during the forecast years.

COMPETITIVE OUTLOOK

Some of the players operating in the intragastric balloon market are Allergan (AbbVie), Obalon Therapeutics, Helioscopie, BAROnova, Apollo Endosurgery Inc, ReShape Lifesciences Inc and Spatz FGIA Inc.